Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Hisashi, Hirakawa"'
Autor:
Shin Takahashi, Nobuaki Sato, Kouji Kaneko, Norikazu Masuda, Masaaki Kawai, Hisashi Hirakawa, Tadashi Nomizu, Hiroji Iwata, Ai Ueda, Takashi Ishikawa, Hiroko Bando, Yuka Inoue, Takayuki Ueno, Shinji Ohno, Makoto Kubo, Hideko Yamauchi, Masahiro Okamoto, Eriko Tokunaga, Shunji Kamigaki, Kenjiro Aogi, Hideaki Komatsu, Masahiro Kitada, Yasuaki Uemoto, Tatsuya Toyama, Yutaka Yamamoto, Toshinari Yamashita, Takehiro Yanagawa, Hiroko Yamashita, Yoshiaki Matsumoto, Masakazu Toi, Minoru Miyashita, Takanori Ishida, Fumiyoshi Fujishima, Satoko Sato, Takuhiro Yamaguchi, Fumiaki Takahashi, Chikashi Ishioka
Publikováno v:
Translational Oncology, Vol 48, Iss , Pp 102060- (2024)
The TP53 signature is considered a predictor of neoadjuvant chemotherapy (NAC) response and prognostic factor in breast cancer. The objective of this study was to confirm TP53 signature can predict pathological complete response (pCR) and prognosis i
Externí odkaz:
https://doaj.org/article/74d2b36fc35b41b88125efdc9ac30b6a
Autor:
Fuzuki Yano, Masatoshi Itoh, Hisashi Hirakawa, Seiichi Yamamoto, Akira Yoshikawa, Jun Hatazawa
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 7, Iss 1, Pp 13-21 (2019)
Objective(s): To investigate the diagnostic accuracy of positron emission mammography (PEM) and positron emission tomography/computed tomography (PET/CT) for small breast tumors of less than 20 mm in size.Methods: The study was conducted on a total o
Externí odkaz:
https://doaj.org/article/367af8e3ce004a7b8b77bdf46ae639f9
Publikováno v:
Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-4 (2017)
Abstract Background Most bone metastases are observed in the trunk of the body. Metastasis in the mandibular condyle is rare. In many case reports, temporary common temporomandibular joint disorder-like symptoms can be a sign of relapse and metastasi
Externí odkaz:
https://doaj.org/article/7a2a9c855d8640c999828609c20e92b2
Autor:
Kohsuke Gonda, Mika Watanabe, Hiroshi Tada, Minoru Miyashita, Yayoi Takahashi-Aoyama, Takashi Kamei, Takanori Ishida, Shin Usami, Hisashi Hirakawa, Yoichiro Kakugawa, Yohei Hamanaka, Ryuichi Yoshida, Akihiko Furuta, Hisatake Okada, Hideki Goda, Hiroshi Negishi, Kensaku Takanashi, Masaru Takahashi, Yuichi Ozaki, Yuka Yoshihara, Yasushi Nakano, Noriaki Ohuchi
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Abstract The quantitative sensitivity and dynamic range of conventional immunohistochemistry (IHC) with 3,3′-diaminobenzidine (IHC-DAB) used in pathological diagnosis in hospitals are poor, because enzyme activity can affect the IHC-DAB chromogenic
Externí odkaz:
https://doaj.org/article/032c680d6f0045e89e611e90cded6e1d
Autor:
Freeha Khalid, Kiyoshi Takagi, Ai Sato, Mio Yamaguchi, Fouzia Guestini, Yasuhiro Miki, Minoru Miyashita, Hisashi Hirakawa, Yasuyo Ohi, Yoshiaki Rai, Yasuaki Sagara, Hironobu Sasano, Takashi Suzuki
Publikováno v:
Breast Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::654fbf042cbacf61efb2e605b3c44ed0
https://doi.org/10.1007/s12282-023-01467-0
https://doi.org/10.1007/s12282-023-01467-0
Autor:
Yasuhiro Miki, Hironobu Sasano, Shimpei Kuniyoshi, Yoshiaki Onodera, Akari Sasaki, Katsuhiko Ono, Naoki Yoshimi, Hisashi Hirakawa, Takanori Ishida, Erina Iwabuchi
Publikováno v:
Pathology International. 69:463-471
Both systemic and intratumoral lipid metabolism have been recently reported to play pivotal roles in both tumor development and progression in various human malignancies including breast cancer. However, its details have remained largely unknown in b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ebcbdc43ef7f0de01843406783f463b
https://doi.org/10.1111/pin.12831
https://doi.org/10.1111/pin.12831
Autor:
Toshifumi Niwa, Shin Ichi Hayashi, Yuri Yamaguchi, Kouki Tsuboi, Hisashi Hirakawa, Takako Ito, Kanami Uchiumi, Nozomi Sato
Publikováno v:
Breast Cancer. 26:459-470
Presently, hormonal therapy targeting estrogen receptors is the most effective treatment available for luminal breast cancer. However, many patients relapse after the therapy. It has been suggested that cancer stem-like cells are involved with hormon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5b1710dddc8d55afad27cb54c783c2e
https://doi.org/10.1007/s12282-018-00944-1
https://doi.org/10.1007/s12282-018-00944-1
Autor:
Hisashi Hirakawa, Takanori Ishida, Yasuhiro Miki, Takashi Suzuki, Hironobu Sasano, Erina Iwabuchi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2581, p 2581 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 5
International Journal of Molecular Sciences
Volume 22
Issue 5
Heterogeneous nuclear ribonucleoprotein K (hnRNPK) transcripts are abundant in estrogen receptor (ER)- or progesterone receptor (PR)-positive breast cancer. However, the biological functions of hnRNPK in the ER-mediated signaling pathway have remaine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c14e549d49a60ba7136ead7d17d6bd
https://pubmed.ncbi.nlm.nih.gov/33806648
https://pubmed.ncbi.nlm.nih.gov/33806648
Autor:
Kentaro Tamaki, Keely May McNamara, Yasuyo Ohi, Saki Nakagawa, Yoshiaki Rai, Minoru Miyashita, Hironobu Sasano, Katsuhiko Ono, Yasuaki Sagara, Takanori Ishida, Hisashi Hirakawa, Noriaki Ohuchi, Fouzia Guestini
Publikováno v:
Breast Cancer Research and Treatment. 173:275-288
Triple-negative breast cancer (TNBC) patients with residual disease following neoadjuvant chemotherapy (NAC) harbor higher risk of relapse, and eventual demise compared to those who achieve pathologic complete response. Therefore, in this study, we a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69fce9d38f18e7f59e993d349b19490c
https://doi.org/10.1007/s10549-018-4985-6
https://doi.org/10.1007/s10549-018-4985-6
Autor:
Takashi Suzuki, Minoru Miyashita, Hisashi Hirakawa, Ayako Kanai, Hironobu Sasano, Takanori Ishida, Yasuhiro Miki, Erina Iwabuchi, George Kijima
Publikováno v:
The Journal of Pathology. 246:379-389
Human epidermal growth factor receptor 2 (HER2) is a target of the HER2 inhibitor trastuzumab, which has been administered to HER2-positive breast cancer patients. However, the therapeutic effects of HER2 inhibitor monotherapy are not always clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab321aa96b5c0a8e79046cade79cc018
https://doi.org/10.1002/path.5148
https://doi.org/10.1002/path.5148